Contineum Therapeutics, Inc.
CTNM
Revenue
0.00
0.000.00%
3 Months ChangeAssets
276.64M
▲85.80M▲44.95%
3 Months ChangeLiabilities
15.65M
▲5.28M▲50.84%
3 Months ChangeFree Cash Flow
-14.46M
▼-6.34M▼-78.02%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-03-05
Form 8-K
ID: 0001628280-26-015159
2026-01-26
Form 8-K
ID: 0001437749-26-002072
2025-12-15
Form 8-K
ID: 0001437749-25-037842
2025-12-11
Form 8-K
ID: 0001437749-25-037547
2025-11-20
Form 8-K
ID: 0001437749-25-035860
2025-10-30
Form 10-Q
ID: 0001437749-25-032427
2025-10-30
Form 8-K
ID: 0001437749-25-032422
2025-09-18
Form 8-K
ID: 0001437749-25-029349
2025-08-05
Form 10-Q
ID: 0001437749-25-024852
2025-08-05
Form 8-K
ID: 0001437749-25-024849